Board of Directors

  • Oliver Technow, CEO, BioVectra Inc. (Chair)
  • Roberto Bellini, President & CEO, BSQUARED Capital (Vice Chair)
  • Andrew Casey, President & CEO, BIOTECanada (Secretary)
  • Gordon McCauley, President and CEO, adMare BioInnovations (Past Chair)
  • Paul Petrelli, Vice-President & General Manager, Gilead Sciences Canada Inc.
  • Tamer Mohamed, Founder & CEO, Aspect Biosystems
  • Karen Heim, Vice President and General Manager, Canada, Alexion Pharmaceuticals
  • Anne Woods, Managing Director, Life Sciences, Banking, RBCx
  • Norma Biln, CEO, Augurex
  • Colleen Coxson, Country Manager, Alnylam Pharmaceuticals
  • Andrew Haigh, President and CEO, Adapsyn Bioscience
  • Brigitte Nolet, President & CEO, Roche Canada Pharma
  • Nancy Pei, Partner, Smart & Biggar
  • Sanj Singh, President & CEO, Temple Therapeutics B.V.
  • Jamie Stiff, Managing Director, Genesys Capital
  • Ali Tehrani, Partner, Amplitude Ventures